The Trump administration's cuts to the U.S. Agency for International Development have had reverberations around the world. The agency, which operated in over 100 nations and employed thousands of ...

June is nationally recognized as Pride Month. We're highlighting stories surrounding the LGBTQ community and its impacts on the Susquehanna Valley.

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

Analysts at Citi said that while the clinical hold impacts the targeted commercial launch of the GS-1720/GS-4182 regimen, previously expected around 2029/2030, they believe the setback is minor, as it ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

Staffers at the remnants of the United States Agency for International Development (USAID), the foreign aid agency dismantled ...

The State Department would not provide data to support the secretary's repeated claim that 85 percent of the US global AIDS program is operational.

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...